Moderna, Inc. reports $1.31 billion revenue for quarter ended September 30, 2026, up 29.2%

ยท MRNA

Moderna, Inc. reported revenue of $1.31 billion for the quarter ended September 30, 2026, an increase of 29.2% from the same quarter a year earlier ($1.02 billion).

For the same period it posted net income of $162 million, or $0.38 per diluted share (-0.51 a year earlier).

That is a net margin of 12.3%.

On Sanad's AAOIFI Standard 21 screen, Moderna, Inc. is currently not compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 16.2% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on November 6, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Moderna, Inc. news